Patent classifications
A61Q19/06
Use of isoleucine N-hexadecanoyl as a “volumizing” and/or “plumping” agent for human skin
The invention relates to the cosmetic use of isoleucine N-hexadecanoyl of formula (I): CH.sub.3(CH.sub.2).sub.14C(O)NHCH(COOH)CH(CH.sub.3)CH.sub.2CH.sub.3 (I) as a volumizing agent and/or as a plumping agent for human skin. The invention also relates to a cosmetic treatment method for obtaining a volumizing and/or plumping effect of the skin of a part of the human body selected from among the breasts, face, cheeks, buttocks and eyelids.
Sodium tetradecyl sulfate formulations for treatment of adipose tissue
Contained herein are compositions, formulations, methods, and kits for treating regional fat deposits and fat-related conditions. Certain methods comprise administering tetradecyl sulfate, tetradecyl sulfate-like compounds, and pharmaceutically or cosmetically acceptable salts, solvates, prodrugs, or esters thereof and a liquid carrier.
Sodium tetradecyl sulfate formulations for treatment of adipose tissue
Contained herein are compositions, formulations, methods, and kits for treating regional fat deposits and fat-related conditions. Certain methods comprise administering tetradecyl sulfate, tetradecyl sulfate-like compounds, and pharmaceutically or cosmetically acceptable salts, solvates, prodrugs, or esters thereof and a liquid carrier.
Compositions for use with a fascia tissue treatment device to reduce cellulite
Compositions for lubricating skin during application of a fascia tissue treatment device, thereby reducing the appearance of cellulite in skin and methods of forming such compositions.
Compositions for use with a fascia tissue treatment device to reduce cellulite
Compositions for lubricating skin during application of a fascia tissue treatment device, thereby reducing the appearance of cellulite in skin and methods of forming such compositions.
ALKYLAMIDO COMPOUNDS AND USES THEREOF
Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.
COMBINATIONS OF PRESERVATIVES FOR HAIR DYES
A cosmetic product for changing the color of keratin fibers, in particular human hair, includes a coloring preparation (F) that is packaged in a reclosable container (C), wherein the coloring preparation (F) includes, in a cosmetic carrier, (a) at least one first preservative from the group of sodium sulfite, potassium sulfite, potassium hydrogen sulfite, sodium hydrogen sulfite, zinc pyrithione, benzoic acid, salicylic acid, sorbic acid, formic acid, propionic acid and the physiologically acceptable salts of the aforementioned acids, and (b) at least one second preservative from the group of 2-phenoxyethanol, benzyl alcohol, 1-phenoxypropan-2-ol, isopropanol and ethanol, and (c) at least one oxidation dye precursor and/or one substantive dye.
A method for changing the color of the hair at the roots of the hair involves the use of such a product.
LUPIN PEPTIDE EXTRACTS AND SKIN FIRMNESS
The present invention relates to the use of a lupin peptide extract to prevent loss of skin firmness or to increase the firmness of skin. Advantageously, the lupin peptide extract can prevent the appearance of cellulite and/or reduce skin cellulite.
LUPIN PEPTIDE EXTRACTS AND SKIN FIRMNESS
The present invention relates to the use of a lupin peptide extract to prevent loss of skin firmness or to increase the firmness of skin. Advantageously, the lupin peptide extract can prevent the appearance of cellulite and/or reduce skin cellulite.
PLANT EXTRACT COMPOSITION FOR REDUCING TOPICAL FAT AND PROMOTING WEIGHT LOSS AS WELL AS APPLICATION THEREOF
Provided is a composition and a pharmaceutical composition for reducing topical fat or promoting weight loss, wherein the composition comprises a plant extract composition comprising resveratrol and turmeric extract and a weight ratio of resveratrol and turmeric extract ranges from 1:30 to 10:1. The composition and the pharmaceutical composition are primarily administered through topical injection to inhibit the growth of fat cells and promote fat cells apoptosis to reduce adipocytes, decrease topical fat deposition, and promote weight loss, without causing inflammation or necrosis on peripheral cells or tissues to avoid severe pain, so as to avoid inflammation, damage, and pain caused by surgical liposuction or non-surgical lipolysis products such as phosphatidylcholine and sodium deoxycholate.